Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization
3
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose Histone deacetylase (HDAC) inhibitors radiosensitize tumor cells. To elucidate mechanisms underlying radiosensitization by HDAC inhibition, understanding of differential contributions of HDAC isotypes is needed. The aim of this study was to investigate involvement of known HDAC isotypes in modulation of cellular radiosensitivity. Materials and Methods Because pharmacologic HDAC inhibitors lack isotype-specificity, RNA interference against 11 HDAC isotypes was used to inhibit HDAC in an isotype-specific manner. Radiation cell survival was evaluated using a clonogenic assay in SQ20B cells transfected with small interfering RNA specifically targeting HDAC isotypes. Immunocytochemistry was performed for detection of !H2AX foci. Protein expression was measured using Western blotting. Results Among 11 HDAC isotypes tested, specific inhibition of 7 isotypes (HDAC1, HDAC3, HDAC4, HDAC6, HDAC7, HDAC10, and HDAC11) enhanced radiation lethality in SQ20B cells. Radiosensitization by inhibition of these HDAC isotypes was accompanied by delay of DNA double strand break repair. Radiosensitivity of SQ20B cells was not altered by selective inhibition of the remaining four isotypes (HDAC2, HDAC5, HDAC8, and HDAC9). Inhibition of HDAC isotypes resulted in downregulation of various proteins involved in pro-survival and DNA damage repair pathways. Conclusion Isotype-specificity exists in HDAC inhibition-induced radiosensitization. Different HDAC isotypes are differentially involved in modulation of cellular radiosensitivity.
Abstract
Purpose Histone deacetylase (HDAC) inhibitors radiosensitize tumor cells. To elucidate mechanisms underlying radiosensitization by HDAC inhibition, understanding of differential contributions of HDAC isotypes is needed. The aim of this study was to investigate involvement of known HDAC isotypes in modulation of cellular radiosensitivity. Materials and Methods Because pharmacologic HDAC inhibitors lack isotype-specificity, RNA interference against 11 HDAC isotypes was used to inhibit HDAC in an isotype-specific manner. Radiation cell survival was evaluated using a clonogenic assay in SQ20B cells transfected with small interfering RNA specifically targeting HDAC isotypes. Immunocytochemistry was performed for detection of !H2AX foci. Protein expression was measured using Western blotting. Results Among 11 HDAC isotypes tested, specific inhibition of 7 isotypes (HDAC1, HDAC3, HDAC4, HDAC6, HDAC7, HDAC10, and HDAC11) enhanced radiation lethality in SQ20B cells. Radiosensitization by inhibition of these HDAC isotypes was accompanied by delay of DNA double strand break repair. Radiosensitivity of SQ20B cells was not altered by selective inhibition of the remaining four isotypes (HDAC2, HDAC5, HDAC8, and HDAC9). Inhibition of HDAC isotypes resulted in downregulation of various proteins involved in pro-survival and DNA damage repair pathways. Conclusion Isotype-specificity exists in HDAC inhibition-induced radiosensitization. Different HDAC isotypes are differentially involved in modulation of cellular radiosensitivity.
참고문헌 (24)
- Witt O, "HDAC family : what are the cancer relevant targets?", Cancer Lett, 277, pp.8~21 (2009)
- Lopez CA, "Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation", Int J Radiat Oncol Biol Phys, 69, pp.214~220 (2007)
- Banuelos CA, "Radiosensitization by the histone deacetylase inhibitor PCI-24781", Clin Cancer Res, 13(22 Pt 1), pp.6816~6826 (2007)
- Geng L, "Histone deacetylase(HDAC)inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer", Cancer Res, 66, pp.11298~11304 (2006)
- Munshi A, "Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci", Mol Cancer Ther, 5, pp.1967~1974 (2006)
- Munshi A, "Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity", Clin Cancer Res, 11, pp.4912~4922 (2005)
- Camphausen K, "Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid", Int J Cancer, 114, pp.380~386 (2005)
- Kim JH, "Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor", Int J Radiat Oncol Biol Phys, 59, pp.1174~1180 (2004)
- Camphausen K, "Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275", Cancer Res, 64, pp.316~321 (2004)
- Camphausen K, "Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation", Clin Cancer Res, 10(18 Pt 1), pp.6066~6071 (2004)
- Kim IA, "Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells : class differences and the potential influence of p53", Clin Cancer Res, 12(3 Pt 1), pp.940~949 (2006)
- Kim IA, "Selective inhibition of Ras, phosphoinositide 3kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines", Cancer Res, 65, pp.7902~7910 (2005)
- Cha TL, "Dual degradation of aurora A and B kinases by the histone deacetylase inhibitor LBH589 induces G2-M arrest and apoptosis of renal cancer cells", Clin Cancer Res, 15, pp.840~850 (2009)
- Hehlgans S, "Double targeting of Survivin and XIAP radiosensitizes 3D grown human colorectal tumor cells and decreases migration", Radiother Oncol, 108, pp.32~39 (2013)
- Kao GD, "Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response", J Cell Biol, 160, pp.1017~1027 (2003)
- 김진호, "Sequence-Dependent Radiosensitization of Histone Deacetylase Inhibitors Trichostatin A and SK-7041", Cancer Research and Treatment, 45(4), pp.334~342 (2013), 대한암학회[DOI]
- Litvinov SV, "Main repair pathways of double-strand breaks in the genomic DNA and interactions between them", Cytol Genet, 48, pp.189~202 (2014)
- Kim GD, "Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase", J Biol Chem, 274, pp.31127~31130 (1999)
- Keen N, "Aurora-kinase inhibitors as anticancer agents", Nat Rev Cancer, 4, pp.927~936 (2004)
- Lin ZZ, "Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption", Int J Cancer, 135, pp.492~501 (2014)
- Tao Y, "Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152", Oncogene, 27, pp.3244~3255 (2008)
- Rodel F, "Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer", Cancer Res, 65, pp.4881~4887 (2005)
- Moussata D, "XIAP as a radioresistance factor and prognostic marker for radiotherapy in human rectal adenocarcinoma", Am J Pathol, 181, pp.1271~1278 (2012)
- Cao C, "XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer", Oncogene, 23, pp.7047~7052 (2004)